Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder.
Clinical trial NCT07391878 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07391878
- Sponsor
- Trigone Pharma Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-15
- Primary completion
- 2027-12-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.